Investigation of platelet measurands in dogs with hematologic neoplasia

• Published in: Veterinary clinical pathology 2022-06, Vol.51 (2), p.216-224
• Main Authors: Phillips, Casey, Naskou, Maria C., Spangler, Elizabeth
• Format: Article
• Language: English
• Subjects: Animals; Blood cancer; Blood Platelets - pathology; Dog Diseases - pathology; Dogs; Hematologic Neoplasms - complications; Hematologic Neoplasms - pathology; Hematologic Neoplasms - veterinary; Hospitals, Animal; Hospitals, Teaching; Humans; leukemia; lymphoma; Mean Platelet Volume - veterinary; Platelet Count - veterinary; platelet‐related indices; Retrospective Studies; Thrombocytopenia; Thrombocytopenia - pathology; Thrombocytopenia - veterinary
• ISSN: 0275-6382; 1939-165X
• DOI: 10.1111/vcp.13089

Introduction Thrombocytopenia has been associated with some neoplastic processes, including hematologic neoplasia. There is no information regarding specific changes in platelet measurands in dogs with hematologic neoplasia compared with healthy dogs. The objectives of our study were to establish RIs, evaluate platelet measurands in dogs with hematologic neoplasia, and compare these measurands in patients with hematologic malignancies with or without thrombocytopenia. Methods This was a retrospective study. Platelet measurands were determined using the ADVIA 120 Hematology analyzer when a CBC was performed and included the platelet count, MPV, platelet distribution width (PDW), plateletcrit (PCT), mean platelet component (MPC), platelet component distribution width (PCDW), mean platelet mass (MPM), platelet mass distribution width (PMDW), and number of large platelets. Reference intervals were determined retrospectively using data from 129 healthy dogs. Patients with hematologic neoplasia (n = 50) were identified through retrospective evaluation of medical records from the Auburn University Veterinary Teaching Hospital and separated into thrombocytopenic (n = 20) and nonthrombocytopenic groups (n = 30). Results Platelet count and PCT were significantly higher in older healthy dogs compared with younger dogs. Significant differences were identified when comparing healthy dogs with those with hematologic neoplasia without thrombocytopenia for PDW, PCDW, PMDW, and the number of large platelets, indicating the presence of more heterogeneous platelets. Thrombocytopenic dogs with hematologic neoplasia had significantly decreased MPCs and increased MPVs, MPMs, and PCDWs compared with nonthrombocytopenic dogs with neoplasia. Conclusions Dogs with hematologic neoplasia had more heterogeneous platelets, whereas thrombocytopenic patients with neoplasia had more activated platelets.